Chang Yoonkyung, Kim Jinkwon, Kim Min Ho, Kim Yong Jae, Song Tae Jin
Department of Neurology, College of Medicine, Ewha Woman's University, Seoul, Korea.
Department of Neurology, College of Medicine, Korea University Guro Hospital, Seoul, Korea.
J Clin Neurol. 2018 Oct;14(4):555-565. doi: 10.3988/jcn.2018.14.4.555.
Interarm differences in the systolic and diastolic blood pressures (IASBD and IADBD, respectively) are found in various populations, including stroke patients, but their significance for stroke outcomes has rarely been reported. We aimed to determine the associations of IASBD and IADBD with early neurological deterioration (END), functional outcome, and mortality.
This study included 1,008 consecutive noncardioembolic cerebral infarction patients who were admitted within 24 hours of onset and had automatic measurements of blood pressures in the bilateral arms. END was assessed within 72 hours of stroke onset according to predefined criteria. A poor functional outcome was defined as a score on the modified Rankin Scale ≥3 at 3 months after the index stroke. All-cause mortality was also investigated during a median follow-up of 24 months. The absolute difference of blood pressure measurements in both arms were used to define IASBD and IADBD.
END occurred in 15.3% (155/1,008) of the patients. A multivariate analysis including sex, age, and variables for which the value was <0.1 in a univariate analysis revealed that IASBD ≥10 mm Hg was significantly associated with END [odds ratio (OR)=1.75, 95% CI=1.02-3.01]. IADBD ≥10 mm Hg was also related to END (OR=3.11, 95% CI=1.61-5.99). Moreover, having both IASBD ≥10 mm Hg and IADBD ≥10 mm Hg was related to a poor functional outcome (OR=2.67, 95% CI=1.36-5.35) and mortality (hazard ratio=7.67, 95% CI=3.76-12.83) even after adjusting for END.
This study suggests that an interarm blood pressure difference of ≥10 mm Hg could be a useful indicator for the risks of END, poor functional outcome, and mortality.
在包括中风患者在内的各种人群中均发现了双臂收缩压和舒张压的差异(分别为IASBD和IADBD),但其对中风预后的意义鲜有报道。我们旨在确定IASBD和IADBD与早期神经功能恶化(END)、功能结局及死亡率之间的关联。
本研究纳入了1008例连续的非心源性脑梗死患者,这些患者在发病24小时内入院,并对双侧手臂进行了血压自动测量。根据预定义标准在中风发作72小时内评估END。功能结局不良定义为首次中风后3个月改良Rankin量表评分≥3分。在中位随访24个月期间还调查了全因死亡率。双臂血压测量的绝对差值用于定义IASBD和IADBD。
15.3%(155/1008)的患者发生了END。多因素分析包括性别、年龄以及单因素分析中P值<0.1的变量,结果显示IASBD≥10 mmHg与END显著相关[比值比(OR)=1.75,95%置信区间(CI)=1.02 - 3.01]。IADBD≥10 mmHg也与END相关(OR = 3.11,95% CI = 1.61 - 5.99)。此外,即使在对END进行校正后,IASBD≥10 mmHg且IADBD≥10 mmHg仍与功能结局不良(OR = 2.67,95% CI = 1.36 - 5.35)和死亡率(风险比=7.67,95% CI = 3.76 - 12.83)相关。
本研究表明,双臂血压差值≥10 mmHg可能是END风险、功能结局不良及死亡率的有用指标。